Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ACETAZOLAMIDE vs ACLARUBICIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ACETAZOLAMIDE vs ACLARUBICIN: Safety Overview

Metric ACETAZOLAMIDE ACLARUBICIN
Total FAERS Reports 2,743 314
Deaths Reported 224 60
Death Rate 8.2% 19.1%
Hospitalizations 1,021 73
Average Patient Age 47.8 yrs 51.1 yrs
% Female Patients 62.7% 47.2%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Strides Pharma Science Limited N/A
Route ORAL N/A
Marketing Status Discontinued N/A